180 Wealth Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

180 Wealth Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-26,950	Closed	-$109K	–	429
2025 Q1	$109K	Sell	26,950 -17,350	-39%	-$57.8K	0.02%	396
2024 Q4	$142K	Buy	44,300 +300	+0.7%	+$1.02K	0.02%	403
2024 Q3	$98.6K	Buy	44,000 +1,250	+3%	+$2.88K	0.02%	435
2024 Q2	$96.2K	Buy	+42,750	New	+$76.1K	0.02%	422

180 Wealth Advisors's CKPT Position: Q2 2025 in Review

180 Wealth Advisors sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 26,950 shares — an estimated $109K sold.

180 Wealth Advisors first reported a position in CKPT in Q2 2024 and held it in 4 quarters. The position peaked at $142K in Q4 2024. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

180 Wealth Advisors reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
180 Wealth Advisors sold 26,950 Checkpoint Therapeutics shares in Q2 2025, an estimated $109K.
180 Wealth Advisors first reported a position in Checkpoint Therapeutics in Q2 2024 and held it in 4 quarters.
180 Wealth Advisors's Checkpoint Therapeutics position peaked at $142K in Q4 2024.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on 180 Wealth Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.